Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chromatin factors: Ready to roll as biomarkers in metastatic colorectal cancer?

13 Sept 2023

Abstract excerpt

Colorectal cancer (CRC) ranks as the third most prevalent cancer globally and stands as the fourth leading cause of cancer-related fatalities in 2020. Survival rates for metastatic disease have slightly improved in recent decades, with clinical trials showing median overall survival of approximately 24-30 months. This progress can be attributed to the integration of chemotherapeutic treatments alongside targeted...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer Immunotherapy and Biomarkers
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37709185
DOI: 10.1016/j.phrs.2023.106924

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chromatin factors: Ready to roll as biomarkers in metastatic colorectal cancer?PMID 37709185Read ↗

Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategiesSemantic proximity Read ↗

Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic ImplicationsSemantic proximity Read ↗

Pathogenesis and biomarkers of colorectal cancer by epigenetic alterationSemantic proximity Read ↗

Novel Genetic and Epigenetic Biomarkers of Prognostic and Predictive Significance in Stage II/III Colorectal CancerSemantic proximity Read ↗

DNA methylation modulates epigenetic regulation in colorectal cancer diagnosis, prognosis and precision medicineSemantic proximity Read ↗

Epigenetic insights in the diagnosis, prognosis, and treatment selection in CRC, an updated reviewSemantic proximity Read ↗

Molecular Network of Colorectal Cancer and Current Therapeutic OptionsSemantic proximity Read ↗

Colorectal cancer: epigenetic alterations and their clinical implications.Semantic proximity Read ↗

Current and future biomarkers in the treatment of colorectal cancerSemantic proximity Read ↗

Comprehensive Landscape of Diagnostic, Prognostic and Predictive Biomarkers in Colorectal Cancer: From Genomics to Multi-Omics Integration in Precision MedicineSemantic proximity Read ↗

Genetic and epigenetic biomarkers for diagnosis, prognosis and treatment of colorectal cancer.Semantic proximity Read ↗

Molecular Landscape and Therapeutic Strategies against Colorectal CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.